OMER Q3 2021 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$300,000

Operating Income

-$40M

Net Income

-$23M

EPS (Diluted)

$-0.36

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$24M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$123M

Total Liabilities

$386M

Stockholders' Equity

-$263M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$26M	-100.0%
Gross Profit	-$300,000	$26M	-101.2%
Operating Income	-$40M	-$25M	-56.6%
Net Income	-$23M	-$38M	+41.0%